Stock Insights: Time Warner, InterMune, First Solar, Trius Therapeutics April 9th
First Solar, Inc. (NASDAQ:FSLR): BofA/Merrill lowered First Solar estimates citing margin pressures and concerns regarding project pipeline growth. Shares are Underperform rated.
Time Warner Inc. (NYSE:TWX): Citigroup raised its price target for Time Warner (NYSE:TWX) to $45 from $40 and Viacom (VIA.B) to $62 from $61 while downgrading CBS (NYSE:CBS), Disney (NYSE:DIS), Discovery (NASDAQ:DISCA), News Corp. (NASDAQ:NWSA), Scripps Networks (NYSE:SNI) to Neutral from Buy. The firm sees limited downside risk for Time Warner and Viacom shares and keeps Buy ratings on both names.
InterMune Inc. (NASDAQ:ITMN): Leerink lowered its price target for InterMune citing lower estimates for Esbriet but maintains an Outperform rating on the stock. The firm believes the company’s progress with Esbriet is being countered by multiple timeline delays in pricing decisions.
Trius Therapeutics, Inc. (NASDAQ:TSRX): Piper Jaffray says Trius Therapeutics remains a top small-cap pick for 2012 and reiterates an Overweight rating on the stock with a $13 price target. The firm believes positive results from the first Phase III tedizolid study dramatically de-risk the ongoing pivotal study with data in early 2013.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.